Bioresearch Group Sp. z o.o.
- Address
- Ul. Sokolowska 9/u2, 01-142 Nadarzyn, Poland
Respiratory Tract Diseases
At Bioresearch Group Sp. z o.o., clinical research in respiratory medicine focuses on Chronic Obstructive Pulmonary Disease (COPD) and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), including cases with comorbid asthma. The trials are designed to explore new treatment options and assess how well emerging therapies may improve symptoms and disease control.
- Testing new therapies for COPD and CRSwNP
- Evaluating treatment effects in patients with comorbid asthma
- Supporting better understanding of respiratory disease management
This work reflects a strong interest in improving care for chronic airway conditions and related inflammatory disease patterns.
Cardiovascular Diseases
The Bioresearch Group site also contributes to cardiovascular research, with studies centered on atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). These trials aim to support safer and more effective approaches for preventing serious clot-related complications and reducing the risk of stroke and systemic embolism.
- Assessing new treatment options for non-valvular atrial fibrillation (NVAF)
- Studying prevention of stroke and systemic embolism
- Evaluating therapies for DVT and PE
The site’s cardiovascular trials support research into both prevention and treatment of thromboembolic disease in adults.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Celon Pharma S.A.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Celon Pharma S.A.4trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Bioresearch Group Sp. z o.o.
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase I/II Study to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of BBT002 in Healthy Volunteers and Patients with COPD, CRSwNP, or Comorbid Asthma | Bambusa Therapeutics Inc. | Phase I | Not Yet Recruiting | — | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cytisine | 1 | Unknown | 2024-11-02 | 2024-11-02 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.